The genetics of normal platelet reactivity

Blood

Volumn 116, Issue 15, 2010, Pages 2627-2634

  Kunicki, Thomas J ^a   Nugent, Diane J ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA TROPOMYOSIN; ALPHA2 INTEGRIN; CD172A TYROSINE PROTEIN PHOSPHATASE NONRECEPTOR TYPE SUBSTRATE 1; CD226 ANTIGEN; COLLAGEN; CYCLOOXYGENASE 1; DYNAMIN III; EH DOMAIN CONTAINING PROTEIN 3; FIBRINOGEN; GLYCOPROTEIN IB; GLYCOPROTEIN VI; IGG FC RECEPTOR TYPE IIA; INTEGRIN; INTEGRIN ALPHAIIBBETA3; JMJC DOMAIN CONTAINING HISTONE DEMETHYLATION PROTEIN 2C; PHOSPHATIDYLINOSITOL 4,5 BIPHOSPHATE 3 KINASE CATALYTIC SUBUNIT GAMMA ISOFORM; PROTEIN; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; SERINE THREONINE PROTEIN KINASE TAO1; SNARE PROTEIN; THROMBIN; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; VON WILLEBRAND FACTOR; WD REPEAT CONTAINING PROTEIN 66;

ALLELE; ANALYTIC METHOD; ANALYZER; CHROMOSOME 12Q; CORONARY ARTERY DISEASE; FIBRINOGEN BLOOD LEVEL; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HUMAN; LIGHT TRANSMISSION AGGREGOMETRY; MEGAKARYOBLAST; MEGAKARYOPOIESIS; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE TRAIT LOCUS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE VOLUME; BLOOD; BLOOD CLOTTING PARAMETERS; CELL SIZE; CHROMOSOME 12; CYTOLOGY; GENETICS; GENOMICS; PHYSIOLOGY; PROCEDURES; RISK FACTOR; THROMBOCYTOPOIESIS;

BLOOD PLATELETS; CELL SIZE; CHROMOSOMES, HUMAN, PAIR 12; CORONARY ARTERY DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; PLATELET AGGREGATION; PLATELET COUNT; PLATELET FUNCTION TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RISK FACTORS; THROMBOPOIESIS;

EID: 77957935532     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-04-262048     Document Type: Review

References (95)

1. O'Donnell CJ, Larson MG, Feng D, et al. Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation. 2001;103(25):3051-3056. (Pubitemid 32587850)
2. Jones CI, Bray S, Garner SF, et al. A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood. 2009;114(7):1405-1416.
3. Dupont A, Fontana P, Bachelot-Loza C, et al. An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood. 2003;101(5):1833-1840. (Pubitemid 36237581)
4. Fontana P, Dupont A, Gandrille S, et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation. 2003;108(8): 989-995. (Pubitemid 37048230)
5. Hetherington SL, Singh RK, Lodwick D, Thompson JR, Goodall AH, Samani NJ. Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP. Arterioscler Thromb Vasc Biol. 2005; 25(1):252-257. (Pubitemid 40054285)
6. Yee DL, Bergeron AL, Sun CW, Dong JF, Bray PF. Platelet hyperreactivity generalizes to multiple forms of stimulation. J Thromb Haemost. 2006;4(9):2043-2050.
7. Yee DL, Sun CW, Bergeron AL, Dong JF, Bray PF. Aggregometry detects platelet hyperreactivity in healthy individuals. Blood. 2005;106(8):2723-2729.
8. Jones CI, Garner SF, Angenent W, et al. Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus. J Thromb Haemost. 2007;5(8):1756-1765. (Pubitemid 47091421)
9. Fontana P, Gandrille S, Remones V, et al. Identification of functional polymorphisms of the thromboxane A2 receptor gene in healthy volunteers. Thromb Haemost. 2006;96(3):356-360. (Pubitemid 44377821)
10. Bray PF, Mathias RA, Faraday N, et al. Heritability of platelet function in families with premature coronary artery disease. J Thromb Haemost. 2007;5(8):1617-1623. (Pubitemid 47091401)
11. Panzer S, Hocker L, Koren D. Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry. Ann Hematol. 2006;85(2):121-125. (Pubitemid 43085307)
12. Gaxiola B, Friedl W, Propping P. Epinephrine-induced platelet aggregation: a twin study. Clin Genet. 1984;26(6):543-548. (Pubitemid 15209293)
13. Richardson M, Robishaw JD. The alpha2A-adrenergic receptor discriminates between Gi heterotrimers of different betagamma subunit composition in Sf9 insect cell membranes. J Biol Chem. 1999;274(19):13525-13533.
14. Siffert W, Rosskopf D, Siffert G, et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet. 1998;18(1):45-48. (Pubitemid 28027877)
15. Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med. 2005;56:17-28. (Pubitemid 40299771)
16. Lasne D, Krenn M, Pingault V, et al. Interdonor variability of platelet response to thrombin receptor activation: influence of PIA2 polymorphism. Br J Haematol. 1997;99(4):801-807. (Pubitemid 28047142)
17. Goodall AH, Curzen N, Panesar M, et al. Increased binding of fibrinogen to glycoprotein III-aproline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J. 1999;20(10):742-747. (Pubitemid 29209907)
18. Michelson AD, Furman MI, Goldschmidt- Clermont P, et al. Platelet GP IIIa PI(A) polymorphisms display different sensitivities to agonists. Circulation. 2000;101(9):1013-1018.
19. Theodoropoulos I, Christopoulos C, Metcalfe P, Dimitriadou E, Economopoulos P, Loucopoulos D. The effect of human platelet alloantigen polymorphisms on the in vitro responsiveness to adrenaline and collagen. Br J Haematol. 2001; 114(2):387-393. (Pubitemid 32762241)
20. Vijayan KV, Bray PF. Molecular mechanisms of prothrombotic risk due to genetic variations in platelet genes: enhanced outside-in signaling through the Pro33 variant of integrin beta3. Exp Biol Med (Maywood). 2006;231(5):505-513.
21. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ. Hereditary variation in platelet integrin alpha2·beta1 copy number is associated with two silent polymorphisms in the alpha2 gene coding sequence. Blood. 1997;89(6):1939-1943. (Pubitemid 27132108)
22. Ajzenberg N, Berroeta C, Philip I, et al. Association of the -92C/G and 807C/T polymorphisms of the alpha2 subunit gene with human platelets alpha2beta1 receptor density. Arterioscler Thromb Vasc Biol. 2005;25(8):1756-1760.
23. Joutsi-Korhonen L, Smethurst PA, Rankin A, et al. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood. 2003;101(11):4372- 4379. (Pubitemid 36857801)
24. Trifiro E, Williams SA, Cheli Y, et al. The low frequency isoform of platelet GPVI (GPVIb) attenuates ligand-mediated signal transduction but not receptor expression or ligand binding. Blood. 2009;114(9):1893-1899.
25. Lopez JA, Ludwig EH, McCarthy BJ. Polymorphism of human glycoprotein Ib α results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. J Biol Chem. 1992;267(14): 10055-10061.
26. Ishida F, Furihata K, Ishida K, et al. The largest variant of platelet glycoprotein Ib α has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine 145. Blood. 1995;86(4):1356-1360.
27. Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, Lopez JA. Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood. 1999;94(1): 186-191. (Pubitemid 29300148)
28. Kuijpers RWAM, Faber NM, Cuypers HTM, Ouwehand WH, Von dem Borne AEGK. NH 2-terminal globular domain of human platelet glycoprotein Ib α has a methionine 145/threonine 145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest. 1992;89(2):381-384.
29. Yabe M, Matsubara Y, Takahashi S, et al. Identification of ADRA2A polymorphisms related to shear-mediated platelet function. Biochem Biophys Res Commun. 2006;347(4):1001-1005. (Pubitemid 44118216)
30. Watkins NA, O'Connor MN, Rankin A, et al. Definition of novel GP6 polymorphisms and major difference in haplotype frequencies between populations by a combination of in-depth exon resequencing and genotyping with tag single nucleotide polymorphisms. J Thromb Haemost. 2006;4(6):1197-1205.
31. Kunicki TJ. The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol. 2002;22(1):14-20. (Pubitemid 34076226)
32. Bennett JS, Catella-Lawson F, Rut AR, et al. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets. Blood. 2001;97(10): 3093-3099.
33. Payne KE, Bray PF, Grant PJ, Carter AM. Beta3 integrin haplotype influences gene regulation and plasma von Willebrand factor activity. Atherosclerosis. 2008;198(2):280-286.
34. van der Pol W, van de Winkel JG. IgG receptor polymorphisms: risk factors for disease. Immunogenetics. 1998;48(3):222-232. (Pubitemid 28352188)
35. Kaski S, Kekomaki R, Partanen J. Systematic screening for genetic polymorphism in human platelet glycoprotein Ib alpha. Immunogenetics. 1996;44(3):170-176. (Pubitemid 26225909)
36. Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM, Kunicki TJ. Nucleotide polymorphisms in the alpha 2 gene define multiple alleles which are associated with differences in platelet alpha 2 beta 1. Blood. 1998;92(7):2382-2388.
37. Di Paola J, Jugessur A, Goldman T, et al. Platelet glycoprotein Ibalpha and integrin alphabeta polymorphisms: gene frequencies and linkage disequilibrium in a population diversity panel. J Thromb Haemost. 2005;3(7):1511-1521. (Pubitemid 41725211)
38. Jacquelin B, Tarantino MD, Kritzik M, et al. Allele-dependent transcriptional regulation of the human integrin alpha 2 gene. Blood. 2001;97(6): 1721-1726. (Pubitemid 32217239)
39. Kalb R, Santoso S, Unkelbach K, Kiefel V, Mueller-Eckhardt C. Localization of the Br polymorphism on a 144 bp Exon of the GPIa gene and its application in platelet DNA typing. Thromb Haemost. 1994;71(5):651-654.
40. Lyman S, Aster RH, Visentin GP, Newman PJ. Polymorphism of human platelet membrane glycoprotein IIb associated with the Bak a/Bak b alloantigen system. Blood. 1990;75(12):2343-2348. (Pubitemid 20202312)
41. Newman PJ, Derbes RS, Aster RH. The human platelet alloantigens, PLA1 and PLA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest. 1989;83(5):1778-1781.
42. Jefferson BK, Foster JH, McCarthy JJ, et al. Aspirin resistance and a single gene. Am J Cardiol. 2005;95(6):805-808.
43. Maree AO, Curtin RJ, Chubb A, et al. Cyclooxygenase-1 haplotype modulates platelet response to aspirin. J Thromb Haemost. 2005; 3(10):2340-2345. (Pubitemid 41727215)
44. Harrison P, Mackie I, Mathur A, et al. Platelet hyper-function in acute coronary syndromes. Blood Coagul Fibrinolysis. 2005;16(8):557-562. (Pubitemid 41658974)
45. Ye Z, Liu EH, Higgins JP, et al. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet. 2006;367(9511):651-658. (Pubitemid 43289155)
46. Freedman ML, Reich D, Penney KL, et al. Assessing the impact of population stratification on genetic association studies. Nat Genet. 2004; 36(4):388-393. (Pubitemid 38437262)
47. Motulsky HJ, Shattil SJ, Insel PA. Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine. Biochem Biophys Res Commun. 1980;97(4):1562-1570.
48. Hoffman BB, Michel T, Brenneman TB, Lefkowitz RJ. Interactions of agonists with platelet alpha 2-adrenergic receptors. Endocrinology. 1982; 110(3):926-932. (Pubitemid 12168246)
49. Freeman K, Farrow S, Schmaier A, Freedman R, Schork T, Lockette W. Genetic polymorphism of the alpha 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans. Am J Hypertens. 1995;8(9):863-869.
50. Kondkar AA, Bray MS, Leal SM, et al. VAMP8/ endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost. 2010;8(2):369-378.
51. Ren Q, Ye S, Whiteheart SW. The platelet release reaction: just when you thought platelet secretion was simple. Curr Opin Hematol. 2008;15(5):537-541.
52. Ren Q, Barber HK, Crawford GL, et al. Endobrevin/VAMP-8 is the primary v-SNARE for the platelet release reaction. Mol Biol Cell. 2007; 18(1):24-33. (Pubitemid 46066707)
53. Di Paola J, Federici AB, Sacchi E, et al. Low platelet alpha 2 beta 1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood. 1999;93(11):3578-3582. (Pubitemid 29249801)
54. Cheli Y, Kunicki TJ. hnRNP L regulates differences in expression of mouse integrin alpha2-beta1. Blood. 2006;107(11):4391-4398. (Pubitemid 43801365)
55. Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol. 2001;88(3):230-235. (Pubitemid 32721947)
56. Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost. 2000;83(2): 316-321. (Pubitemid 30093238)
57. Chakroun T, Gerotziafas G, Robert F, et al. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor. Br J Haematol. 2004;124(1):80-85.
58. Kunicki TJ, Williams SA, Salomon DR, et al. Genetics of platelet reactivity in normal, healthy individuals. J Thromb Haemost. 2009;7(12):2116-2122.
59. Evans DM, Frazer IH, Martin NG. Genetic and environmental causes of variation in basal levels of blood cells. Twin Res. 1999;2(4):250-257.
60. Mahaney MC, Brugnara C, Lease LR, Platt OS. Genetic influences on peripheral blood cell counts: a study in baboons. Blood. 2005;106(4): 1210-1214. (Pubitemid 41129581)
61. Mayda-Domac F, Misirli H, Yilmaz M. Prognostic role of mean platelet volume and platelet count in ischemic and hemorrhagic stroke. J Stroke Cerebrovasc Dis. 2010;19(1):66-72.
62. Martin JF, Bath PM, Burr ML. Mean platelet volume and myocardial infarction. Lancet. 1992; 339(8799):1000-1001.
63. Boos CJ, Lip GY. Assessment of mean platelet volume in coronary artery disease: what does it mean? Thromb Res. 2007;120(1):11-13.
64. Bath P, Algert C, Chapman N, Neal B. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004;35(3):622-626. (Pubitemid 38280830)
65. De Luca G, Santagostino M, Secco GG, et al. Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis. 2009;206(1):292-297.
66. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8(1):148-156.
67. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J. 2001;22(17):1561-1571.
68. Soranzo N, Rendon A, Gieger C, et al. A novel variant on chromosome 7q22.3 associated with mean platelet volume, counts, and function. Blood. 2009;113(16):3831-3837.
69. Soranzo N, Spector TD, Mangino M, et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet. 2009; 41(11):1182-1190.
70. Meisinger C, Prokisch H, Gieger C, et al. A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet. 2009;84(1):66-71.
71. Hawkins PT, Stephens LR. PI3Kgamma is a key regulator of inflammatory responses and cardiovascular homeostasis. Science. 2007;318(5847): 64-66.
72. Pasquet JM, Gross BS, Gratacap MP, et al. Thrombopoietin potentiates collagen receptor signaling in platelets through a phosphatidylinositol 3-kinase-dependent pathway. Blood. 2000; 95(11):3429-3434.
73. Hirsch E, Bosco O, Tropel P, et al. Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J. 2001;15(11):2019-2021.
74. Tertyshnikova S, Fein A. Inhibition of inositol 1,4,5-trisphosphate- induced Ca2+ release by cAMP-dependent protein kinase in a living cell. Proc Natl Acad Sci U S A. 1998;95(4):1613-1617.
75. Wojcikiewicz RJ, Luo SG. Phosphorylation of inositol 1,4,5-trisphosphate receptors by cAMP-dependent protein kinase: type I, II, and III receptors are differentially susceptible to phosphorylation and are phosphorylated in intact cells. J Biol Chem. 1998;273(10):5670-5677.
76. Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. The ancient regulatory-protein family of WD-repeat proteins. Nature. 1994;371(6495):297-300. (Pubitemid 24300613)
77. Arthur WT, Ellerbroek SM, Der CJ, Burridge K, Wennerberg K. XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC. J Biol Chem. 2002;277(45):42964-42972. (Pubitemid 35285675)
78. Thiesen S, Kubart S, Ropers HH, Nothwang HG. Isolation of two novel human RhoGEFs, ARHGEF3 and ARHGEF4, in 3p13-21 and 2q22. Biochem Biophys Res Commun. 2000;273(1):364-369. (Pubitemid 30426912)
79. Draviam VM, Stegmeier F, Nalepa G, et al. A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling. Nat Cell Biol. 2007;9(5):556-564. (Pubitemid 46696537)
80. Weedon MN, Lango H, Lindgren CM, et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet. 2008; 40(5):575-583. (Pubitemid 351601210)
81. Reems JA, Wang W, Tsubata K, et al. Dynamin 3 participates in the growth and development of megakaryocytes. Exp Hematol. 2008;36(12): 1714-1727.
82. Ma D, Sun Y, Lin D, et al. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization. Eur J Haematol. 2005;74(3):228-240. (Pubitemid 40278493)
83. Kitajima K, Kojima M, Kondo S, Takeuchi T. A role of jumonji gene in proliferation but not differentiation of megakaryocyte lineage cells. Exp Hematol. 2001;29(4):507-514. (Pubitemid 32297675)
84. Sun L, Gorospe JR, Hoffman EP, Rao AK. Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: insights from platelet expression profiling. J Thromb Haemost. 2007;5(1):146-154. (Pubitemid 44921080)
85. Barclay AN. Signal regulatory protein alpha (SIRPalpha)/ CD47 interaction and function. Curr Opin Immunol. 2009;21(1):47-52.
86. Naslavsky N, McKenzie J, Altan-Bonnet N, Sheff D, Caplan S. EHD3 regulates early-endosome-to-Golgi transport and preserves Golgi morphology. J Cell Sci. 2009;122(3):389-400.
87. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128(6):1173-1186.
88. Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29(4):465-468. (Pubitemid 34326699)
89. Merched AJ, Chan L. Absence of p21Waf1/Cip1/ Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis. Circulation. 2004;110(25):3830-3841. (Pubitemid 40023982)
90. Wickrema A, Crispino JD. Erythroid and megakaryocytic transformation. Oncogene. 2007; 26(47):6803-6815.
91. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature. 2007;447(7145):661-678.
92. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357(5):443-453. (Pubitemid 47204873)
93. Coronary Artery Disease Consortium, Samani NJ, Deloukas P, et al. Large scale association analysis of novel genetic loci for coronary artery disease. Arterioscler Thromb Vasc Biol. 2009;29(5):774-780.
94. Myocardial Infarction Genetics Consortium, Kathiresan S, Voight BF, et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009;41(3):334-341.
95. Johnson AD, O'Donnell CJ. An open access database of genome-wide association results. BMC Med Genet. 2009;10:6.